CD Genomics, a world-leading company in genomic services, today announced that members of its management team would participate in the 37th Society for Immunotherapy of Cancer’s (SITC) Annual Meeting in Boston, MA, November 8-12, 2022.
Details for the 37th Annual Meeting & Pre-Conference Programs (SITC 2022)
The 37th Annual Meeting & Pre-Conference Programs (SITC 2022) provides a multidisciplinary educational and interactive environment focused on improving outcomes for current and future patients with cancer by incorporating strategies based on basic and applied cancer immunotherapy. The Annual Meeting consists of cutting-edge research presentations by experts in the field, oral and poster abstract presentations, and ample opportunity for structured and informal discussions, including important networking opportunities. In addition, the meeting includes updates on major national and international initiatives coming from academia, government, and industry, as well as important society projects.
Date: Nov 8-12, 2022
Location: Boston, MA or Virtual
CD Genomics is glad to be physically presenting itself at the SITC 2022 finally. The event represents one of the largest and most skilled gatherings of diversity in the biotechnology and life science representatives held globally today. In addition, it is the world’s leading member-driven organization specifically dedicated to improving cancer patient outcomes by advancing the science and application of cancer immunotherapy. Through educational programs that foster scientific exchange and collaboration, SITC aims to one day make the word “cure” a reality for cancer patients everywhere.
CD Genomics is, as always, excited to meet with teams behind some of the most innovative solutions available today and perhaps to explore the role our new technologies may have in realizing these solutions.
Will you be at the SITC 2022 this year? Come visit the CD Genomics Team in the exhibit hall, Booth #647. In addition to the exhibition, scientists from CD Genomics will be presenting posters regarding new technologies and platforms.
“CD Genomics is proud to exhibit and participate at the SITC 2022. Our experts will be on-hand in our booth throughout the show to connect and speak with you one-on-one. Come visit us to learn more about our exciting products and services that can help streamline your research and scientific projects,” commented Dianna Gellar, business development executive of CD Genomics.
About CD Genomics
CD Genomics is a genomic service provider well-known for reliable sequencing and bioinformatic analysis, aiming to deliver high-quality next-generation sequencing, long-read sequencing, genotyping, and microarray services for the research community.
Address: Shirley, NY 11967, USA